Evidence map›Paper›PMID 37965323›Full record

ArticleFrontiers in immunology2023

Myeloid

Xiaolong Dai, Lianlian Li, Xinrong Yan, Qianqian Fan, Ruizhen Wang, Wenhao Zhang, Weiwei Chen, Yang Liu, Jianghui Meng, Jiafu Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Vamp3/syntaxin 4 mediates the basolateral membrane fusion of TfR transcytosis across the BBB and is exploited by pathogenicProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Comprehensive analysis of myeloid reporter mice.bioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Xiaolong DaiSchool of Life Sciences, Henan University, Kaifeng, China.
Lianlian LiSchool of Life Sciences, Henan University, Kaifeng, China.
Xinrong YanSchool of Life Sciences, Henan University, Kaifeng, China.
Qianqian FanSchool of Life Sciences, Henan University, Kaifeng, China.
Ruizhen WangSchool of Life Sciences, Henan University, Kaifeng, China.
Wenhao ZhangSchool of Life Sciences, Henan University, Kaifeng, China.
Weiwei ChenSchool of Life Sciences, Henan University, Kaifeng, China.
Yang LiuSchool of Life Sciences, Henan University, Kaifeng, China.
Jianghui MengSchool of Life Sciences, Henan University, Kaifeng, China.
Jiafu WangSchool of Life Sciences, Henan University, Kaifeng, China.
Henan University · CNDublin City University · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Persistent inflammation and associated pain significantly impact individuals' quality of life, posing substantial healthcare challenges. Proinflammatory cytokines, released by activated macrophages, play crucial roles in the development of chronic inflammatory conditions such as rheumatoid arthritis. To identify and evaluate potential therapeutic interventions targeting this process for mitigating inflammation and pain, we created myeloid cell-specific knockout of

Indexed as

Interleukin-6Tumor Necrosis Factor-alphaAnimalsCytokinesFreund's AdjuvantHyperalgesiaInflammationMacrophages, PeritonealMicePainQuality of LifeVesicle-Associated Membrane Protein 3CytokinesFreund's AdjuvantInterleukin-6Tumor Necrosis Factor-alphaVesicle-Associated Membrane Protein 3vesicle-associated membrane protein 3, mousecytokineinflammationneuropeptidespainrheumatoid arthritisSNAREtherapeuticsvesicle associated membrane protein

Identifiers

PMID37965323
PMCPMC10641732
OpenAlexW4387998748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.